Tag: DNX Biopharmaceuticals
DNX Biopharmaceuticals Announces Collaboration with Lung Cancer Initiative at Johnson &...
DNX Biopharmaceuticals, a biopharmaceutical company developing long-acting therapeutic proteins for the treatment of patients with life-long diseases and a resident of Johnson...